MX9710147A - Inhibidores de la ribonucleotido-reductasa de herpes. - Google Patents

Inhibidores de la ribonucleotido-reductasa de herpes.

Info

Publication number
MX9710147A
MX9710147A MX9710147A MX9710147A MX9710147A MX 9710147 A MX9710147 A MX 9710147A MX 9710147 A MX9710147 A MX 9710147A MX 9710147 A MX9710147 A MX 9710147A MX 9710147 A MX9710147 A MX 9710147A
Authority
MX
Mexico
Prior art keywords
reductase inhibitors
ribonucleotide reductase
herpes ribonucleotide
herpes
alkyl
Prior art date
Application number
MX9710147A
Other languages
English (en)
Other versions
MXPA97010147A (es
Inventor
Jean-Andre Gauthier
Neil Moss
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of MX9710147A publication Critical patent/MX9710147A/es
Publication of MXPA97010147A publication Critical patent/MXPA97010147A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen aquí compuestos de la formula en la que R1 es hidrogeno a alquilo (C1-C4) y R2 es alquilo (C1-C4); o una de sus sales terapéuticamente aceptables. Los compuestos son utiles para tratar infecciones por herpes.
MXPA/A/1997/010147A 1995-06-23 1997-12-15 Inhibidores de la ribonucleotido-reductasa deherpes MXPA97010147A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002152541A CA2152541C (en) 1995-06-23 1995-06-23 Herpes ribonucleotide reductase inhibitors
CA2152541 1995-06-23
PCT/CA1996/000180 WO1997000855A1 (en) 1995-06-23 1996-03-27 Herpes ribonucleotide reductase inhibitors

Publications (2)

Publication Number Publication Date
MX9710147A true MX9710147A (es) 1998-03-31
MXPA97010147A MXPA97010147A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
EP0837845A1 (en) 1998-04-29
ATE209628T1 (de) 2001-12-15
CA2152541C (en) 1998-12-15
EP0837845B1 (en) 2001-11-28
IL118705A0 (en) 1996-10-16
WO1997000855A1 (en) 1997-01-09
DE69617433D1 (de) 2002-01-10
DE69617433T2 (de) 2002-06-27
JPH11508246A (ja) 1999-07-21
CA2152541A1 (en) 1996-12-24
AR002541A1 (es) 1998-03-25
AU5097796A (en) 1997-01-22
ZA965272B (en) 1996-12-23
US5672586A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
BG101833A (en) Guanine derivative
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
TW334435B (en) Bicyclic amines
ES2176402T3 (es) Compuestos sulfatos de 2,2-difluoro-3-carbomoil-ribosa y procedimientopara la preparacion de beta-nucleosidos.
MX9709867A (es) Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos.
GB9607380D0 (en) Synergistic stabilizer mixture
HK1018208A1 (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
PL315169A1 (en) Tetrahydrofuranic antimycotic agents
AU3744397A (en) Total synthesis of antitumor acylfulvenes
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
MX9602861A (es) Mezcla estabilizante sinergistica.
AU8350698A (en) Metalloproteinase inhibitors
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
MX9708696A (es) Cefalosporinas antibacterianas.
AU9066498A (en) Substituted 6-alkylphenanthridines
MX9801190A (es) Inhibidores de prolil endopeptidasa.
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
JO2065B1 (en) Tri-azin compounds
MX9710147A (es) Inhibidores de la ribonucleotido-reductasa de herpes.
IL118668A0 (en) Tetrahydrofuran antifungals
AU3739595A (en) Antiherpes peptidomimetic compounds
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
CA2187849A1 (en) Uck14 compounds
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
MX9704737A (es) Derivados de tienoxazinona utiles como agentes antivirales.